Decrease expression of microRNA-20a promotes cancer cell proliferation and predicts poor survival of hepatocellular carcinoma

Journal of Experimental and Clinical Cancer Research

Volumn 32, Issue 1, 2013, Pages

  Fan, Ming Qi ^a   Huang, Chi Bing ^a   Gu, Yan ^b   Xiao, Ya ^a   Sheng, Jin Xin ^b   Zhong, Lin ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Hepatocellular Carcinoma; Liver transplantation; MicroRNA 20a; Prognosis; Recurrence

Indexed keywords

MICRORNA 20A; PROTEIN MCL 1; MICRORNA; MIRN20 MICRORNA, HUMAN;

ADULT; APOPTOSIS; ARTICLE; CANCER CELL; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENCE FREE SURVIVAL; BIOSYNTHESIS; CELL GROWTH; DISEASE COURSE; GENETICS; HEPG2 CELL LINE; LIVER TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; TUMOR RECURRENCE;

CARCINOMA, HEPATOCELLULAR; CELL GROWTH PROCESSES; DISEASE PROGRESSION; FEMALE; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84876184639     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-32-21     Document Type: Article

References (29)

1. Global cancer statistics. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D, CA Cancer J Clin 2011 61 69 90 10.3322/caac.20107 21296855
2. Transplantation for liver and biliary cancer. Strong RW, Semin Surg Oncol 2000 19 189 199 10.1002/1098-2388(200009)19:2<189::AID-SSU10>3.0.CO;2-U 11126382
3. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. El-Serag HB, Rudolph KL, Gastroenterology 2007 132 2557 2576 10.1053/j.gastro.2007.04.061 17570226 (Pubitemid 46890874)
4. MicroRNAs in human cancer: from research to therapy. Negrini M, Ferracin M, Sabbioni S, Croce CM, J Cell Sci 2007 120 1833 1840 10.1242/jcs.03450 17515481 (Pubitemid 46979774)
5. MicroRNAs: genomics, biogenesis, mechanism, and function. Bartel DP, Cell 2004 116 281 297 10.1016/S0092-8674(04)00045-5 14744438 (Pubitemid 38167318)
6. A microRNA expression signature of human solid tumors defines cancer gene targets. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Proc Natl Acad Sci USA 2006 103 2257 2261 10.1073/pnas.0510565103 16461460 (Pubitemid 43271657)
7. MicroRNA-20a overexpression inhibited proliferation and metastasis of pancreatic carcinoma cells. Yan H, Wu J, Liu W, Zuo Y, Chen S, Zhang S, Zeng M, Huang W, Hum Gene Ther 2010 21 1723 1734 10.1089/hum.2010.061 20583868
8. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DLW, Au GKH, JAMA 2008 299 425 10.1001/jama.299.4.425 18230780 (Pubitemid 351185951)
9. Identification and functional characterization of microRNAs involved in the malignant progression of gliomas. Malzkorn B, Wolter M, Liesenberg F, Grzendowski M, Stühler K, Meyer HE, Reifenberger G, Brain Pathol 2010 20 539 550 10.1111/j.1750-3639.2009.00328.x 19775293
10. MicroRNAs MiR-17, MiR-20a, and MiR-106b act in concert to modulate E2F activity on cell cycle arrest during neuronal lineage differentiation of USSC. Trompeter HI, Abbad H, Iwaniuk KM, Hafner M, Renwick N, Tuschl T, Schira J, Müller HW, Wernet P, PLoS One 2011 6 16138 10.1371/journal.pone.0016138 21283765
11. Identification of recurrence related microRNAs in hepatocellular carcinoma following liver transplantation.pdf. Han ZB ZL, Teng MJ, Fan JW, Tang HM, Wu JY, Chen HY WZW, Qiu GQ, Peng ZH, Mol Oncol 2012 6 445 457 10.1016/j.molonc.2012.04.001 22552153
12. Mcl-1 is a potential therapeutic target in multiple types of cancer. Akgul C, Cell Mol Life Sci 2009 66 1326 1336 10.1007/s00018-008-8637-6 19099185
13. Mcl-1 is an anti-apoptotic factor for human hepatocellular carcinoma. Fleischer B, Schulze-Bergkamen H, Schuchmann M, Weber A, Biesterfeld S, Müller M, Krammer PH, Galle PR, Int J Oncol 2006 28 25 16327976
14. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, Camerini T, Roayaie S, Schwartz ME, Grazi GL, Lancet Oncol 2009 10 35 43 10.1016/S1470-2045(08)70284-5 19058754
15. Liver transplantation for hepatocellular carcinoma: Hangzhou experiences. Zheng SS, Xu X, Wu J, Chen J, Wang WL, Zhang M, Liang TB, Wu LM, Transplantation 2008 85 1726 10.1097/TP.0b013e31816b67e4 18580463
16. Real-time quantification of microRNAs by stem-loop RT-PCR. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, Nucleic Acids Res 2005 33 179 10.1093/nar/gni178 16314309 (Pubitemid 41806407)
17. MicroRNA expression profiles predictive of human renal allograft status. Anglicheau D, Sharma VK, Ding R, Hummel A, Snopkowski C, Dadhania D, Seshan SV, Suthanthiran M, Proc Natl Acad Sci 2009 106 5330 10.1073/pnas.0813121106 19289845
18. Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy. Maddika S, Ande SR, Panigrahi S, Paranjothy T, Weglarczyk K, Zuse A, Eshraghi M, Manda KD, Wiechec E, Los M, Drug Resist Updat 2007 10 13 29 10.1016/j.drup.2007.01.003 17303468 (Pubitemid 46636381)
19. MicroRNA-125b promotes apoptosis by regulating the expression of Mcl-1, Bcl-w and IL-6R. Gong J, Zhang J, Li B, Zeng C, You K, Chen M, Yuan Y, Zhuang S, Oncogene 2012 10.1038/onc.2012.318
20. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP, Liu CG, Bhatt D, Taccioli C, Croce CM, JAMA 2007 297 1901 1908 10.1001/jama.297.17.1901 17473300 (Pubitemid 46707844)
21. MicroRNA gene expression deregulation in human breast cancer. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Cancer Res 2005 65 7065 10.1158/0008-5472.CAN-05-1783 16103053 (Pubitemid 41161233)
22. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Cancer Cell 2006 9 189 198 10.1016/j.ccr.2006.01.025 16530703 (Pubitemid 43357945)
23. Survival prediction of gastric cancer by a seven-microRNA signature. Li X, Zhang Y, Ding J, Wu K, Fan D, Gut 2010 59 579 585 10.1136/gut.2008.175497 19951901
24. microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity. Zhang J, Yang Y, Yang T, Liu Y, Li A, Fu S, Wu M, Pan Z, Zhou W, Br J Cancer 2010 103 1215 1220 10.1038/sj.bjc.6605895 20842113
25. MicroRNA signatures in human cancers. Calin GA, Croce CM, Nat Rev Cancer 2006 6 857 866 10.1038/nrc1997 17060945 (Pubitemid 44629897)
26. Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. Matsubara H, Takeuchi T, Nishikawa E, Yanagisawa K, Hayashita Y, Ebi H, Yamada H, Suzuki M, Nagino M, Nimura Y, Oncogene 2007 26 6099 6105 10.1038/sj.onc.1210425 17384677 (Pubitemid 47373805)
27. Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy. Sieghart W, Losert D, Strommer S, Cejka D, Schmid K, Rasoul-Rockenschaub S, Bodingbauer M, Crevenna R, Monia BP, Peck-Radosavljevic M, J Hepatol 2006 44 151 157 10.1016/j.jhep.2005.09.010 16289418 (Pubitemid 41772529)
28. Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction. Schulze-Bergkamen H, Fleischer B, Schuchmann M, Weber A, Weinmann A, Krammer P, Galle P, BMC Cancer 2006 6 232 10.1186/1471-2407-6-232 17014711 (Pubitemid 44575143)
29. Mcl-1 is overexpressed in multiple myeloma and associated with relapse and shorter survival. Wuilleme-Toumi S, Robillard N, Gomez P, Moreau P, Le Gouill S, Avet-Loiseau H, Harousseau J, Amiot M, Bataille R, Leukemia 2005 19 1248 1252 10.1038/sj.leu.2403784 15902294 (Pubitemid 40946011)